Dizocilpine maleate, and N-methyl-D-aspartate antagonist, inhibits dipsogenic responses and c-fos expression induced by intracerebral infusion of angiotensin II

Neuroscience

Volumn 78, Issue 1, 1997, Pages 203-214

  Xu, Z ^a   Lane, J M ^a   Zhu, B ^a   Herbert, J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

angiotensin II; c fos expression; glutamate antagonists; mecamylamine; NMDA receptor; thirst

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 7 CHLOROKYNURENIC ACID; ANGIOTENSIN; DIZOCILPINE; GAMMA GLUTAMYLGLYCINE; MECAMYLAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICOTINIC RECEPTOR; TENOCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRINKING; GENE EXPRESSION; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; ONCOGENE C FOS; PARABRACHIAL NUCLEUS; PRIORITY JOURNAL; RAT; SOLITARY TRACT NUCLEUS;

EID: 0030938962     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(96)00564-7     Document Type: Article

References (60)

1. Arnauld E., Cirino M., Layton B. S. and Renaud L. P. (1983) Contrasting actions of amino acids, acetylcholine, noradrenaline and leucine enkephaline on the excitability of synaptic vasopressin-secreting neurons. Neuroendocrinology 36, 187-196.
2. Arnold J. L., de Lucas Bueno M., Shiers H., Hancock D. C., Evan G. I. and Herbert J. (1992) Expression of c-fos in regions of the basal limbic forebrain following intraventricular corticotropin-releasing factor in unstressed or stressed male-rats. Neuroscience 51, 377-390.
3. Bading H., Segal M. M., Secher N. J., Dudek H. and Lipton S. A. (1995) N-Methyl-D-aspartate receptors are critical for mediating the effects of glutamate on intracellular calcium concentration and immediate early gene expression in cultured hippocampal neurons. Neuroscience 64, 653-664.
4. Baron S. P. and Woods J. H. (1993) Dipsogenic effects of excitatory acid agonists in pigeons. J. Pharmac. exp. Ther. 264, 918-921.
5. Buggy J. and Johnson A. K. (1977) Anteroventral third ventricle periventricular ablation: temporary adipsia and persisting thirst deficits. Neurosci. Lett. 5, 177-182.
6. Buggy J. and Johnson A. K. (1977) Preoptic-hypothalamic periventricular lesions: thirst deficits and hypernatremia. Am. J. Physiol. 233, R44-R52.
7. Buggy J. and Johnson A. K. (1978) Angiotensin-induced thirst: effects of third ventricle obstruction and periventricular ablation. Brain Res. 149, 117-128.
8. Chapman A. G., Meldrum B. S., Nanji N. and Watkins J. C. (1987) Anticonvulsant action and biochemical effects in DBA/2 mice of CPP (3-((±)-2carboxypiperazin-4-yl)-propyl-1-phosphonate), a novel N-methyl-D-aspartate antagonist. Eur. J. Pharm. 139, 91-96.
9. Chaudhry M. A., Dyball R. E. J., Honda K. and Wright N. C. (1989) The role of interconnections between supraoptic nucleus and anterior third ventricular region in osmoregulation in the rat. J. Physiol., Lond. 410, 123-135.
10. Chew B. H., Weaver D., Balaban C. D. and Gross P. M. (1994) NMDA-mediated metabolic activation of the cerebellar cortex in behaving rats by neuropeptide endothelin-1. Brain Res. 647, 345-352.
11. Cunningham J. T. and Johnson A. K. (1989) Decreased norepinephrine in the ventral lamina terminalis region is associated with angiotensin II drinking response deficits following local 6-hydroxydopamine injections. Brain Res. 480, 65-71.
12. Darlington D. N., Miyamoto M., Keil L. C. and Dallman M. F. (1989) Paraventricular stimulation with glutamate elicits bradycardia and pituitary responses. Am. J. Physiol. 256, R112-R119.
13. Fitzsimons J. T. and Setler P. E. (1975) The relative importance of central nervous catechlolaminergic and cholinergic mechanisms in drinking in response to angiotensin and other thirst stimuli. J. Physiol., Lond. 250, 613-631.
14. Foster A. C. (1991) Channel blocking drugs for the NMDA receptor. In Excitatory Amino Acid Antagonists (ed. Meldrum B. S.), pp. 164-179. Blackwell Scientific, Oxford.
15. Foster A. C. and Fagg G. E. (1987) Taking apart NMDA receptors. Nature 329, 395-396.
16. Gozlan H., Khazipov R., Diabire D. and Benari Y. (1995) In CA1 hippocampal neurons, the redox state of NMDA receptors determines LTP expressed by NMDA but not by AMPA receptors. J. Neurophysiol. 73, 2612-2617.
17. Gray T. S., Cassell M. D., William T. H., Lind R. W. and Johnson A. K. (1982) The subfornical organ-median preoptic pathway: evidence suggesting that an AII-like substance may be a neurotransmitter in this projection. Neurosci. Abstr. 8, 102.
18. Herbert J. (1993) Peptides in the limbic system: neurochemical codes for co-ordinating adaptive responses to behavioural and physiological demand. Prog. Neurobiol. 41, 723-791.
19. Herbert J., Fosling M. L., Howes S. R., Stacey P. M. and Shiers H. M. (1992) Regional expression of c-fos antigen in the basal forebrain following intraventricular infusion of angiotensin and its modulation by drinking either water or saline. Neuroscience 51, 867-882.
20. Hollmann M., Boulter J., Maron C., Beasley L., Sullivan J., Pecht G. and Heinemann S. (1993) Zinc potentiates agonist-induced currents at splice variants of the NMDA receptor. Neuron 10, 943-954.
21. Hu B. and Bourgue C. (1991) Functional N-methyl-D-asparate and non-N-methyl-D-asparate receptors are expressed by rat supraoptic neurosecretory cells in vitro. J. Neuroendocr. 3, 509-514.
22. Jane D. E. and Oliverman H. J. and Watkins J. C. (1994) Agonists and competitive antagonists: structure-activity and molecular modelling studies. In The NMDA Receptors (eds Collingridge G. L. and Watkins J. C.), pp. 31-104. Oxford University Press, Oxford.
23. 3H]thienyl)cyclohexyl] piperidine recognition sites in the brain and spinal cord: differential effects of NMDA agonists and antagonists. J. Neurochem. 63, 1757-1765.
24. Laurie D. J. and Seeburg P. H. (1994) Ligand affinities at recombinant N-methyl-D-asparatate receptors depend on subunit composition. Eur. J. Pharmac. 268, 335-345.
25. Lee S., River C. and German T. (1994) Induction of c-fos mRNA by MK-801 in the parvicellular paraventricular nucleus of the rat hypothalamus. Molec. Brain Res. 24, 192-198.
26. Lind R. W. and Johnson A. K. (1983) A further characterization of the effects of AV3V lesions on ingestive behaviour. Am. J. Physiol. 245, R83-R90.
27. Luckman S. M., Dyball R. E. and Leng G. J. (1994) Induction of c-fos expression in hypothalamic magnocellular neurons requires synaptic activation and simply increased spike activity. J. Neurosci. 14, 4825-4830.
28. Mahon J., Fitzsimons J. T. and Herbert J. (1995) The association between behavioural and endocrine effects of intracereboventricular infusions of angiotensin II, angiotensin(1-7) or carbachol and c-fos expression in the rat. Neuroscience 69, 199-208.
29. Mangiapane M. L. and Simpson J. B. (1980) Subfornical organ: forebrain site of pressor and dipsogenic action of angiotensin II. Am. J. Physiol. 239, R382-R389.
30. Mangiapane M. J., Thrasher T. N., Keil L. C., Simpson J. B. and Ganong W. F. (1983) Deficits in drinking and vasopressin secretion after lesions of the nucleus medians. Neuroendocrinology 37, 73-77.
31. Marvizon J. C. and Baudry M. (1994) Allosteric interactions and modulator requirement for NMDA receptor function. Eur. J. Pharmac. 269, 165-175.
32. McBain C. J. and Mayer M. L. (1994) N-Methyl-D-aspartic acid receptor structure and function. Physiol. Rev. 74, 723-760.
33. Meeker R. B., Greenwood R. S. and Hayward J. N. (1994) Glutamate receptors in the rat hypothalamic and pituitary. Endocrinology 134, 621-629.
34. Meeker R. B., Swanson D. J. and Hayward J. N. (1989) Light and electron microscopic localization of glutamate immunoreactivity in the supraoptic nucleus of the rat hypothalamus. Neuroscience 33, 157-167.
35. Miselis R. (1981) The efferent projections of the subfornical organ of the rat: a circumventricular organ within a neural network subserving water balance. Brain Res. 230, 1-23.
36. Nakanishi S. (1992) Molecular diversity of glutamate receptors and implications for brain functions. Science, NY 258, 597-603.
37. Parker S. L. and Crowley W. R. (1993) Stimulation of oxytocin release in the lactating rat by central excitatory amino acid mechanism: evidence for specific involvement of R,S-α-amino-3-hydroxy-5-methylisoxazole-4-propionic-acid-sensitive glutamate receptor. Endocrinology 133, 2847-2854.
38. Pechnick R. N., George R. and Poland R. E. (1989) Characterization of the effects of acute and repeated administration of MK-801 on the release of adrenocorticotropin, corticosterone and prolactin in the rat. Eur. J. Pharmac. 164, 257-263.
39. Petraglia R. S., Wang Y.-X. and Wenthold R. J. (1994) The NMDA receptor subunits NR2A and NR2B show histological and ultrastructural localization patterns similar to those of NR1. J. Neurosci. 14, 6102-6120.
40. Ramoa A. S., Alkondon Y., Aracava J., Irons G. G., Lunt S. S., Deshpande S., Wonnacott R. S., Aronstam R. S. and Albuquerque E. X. (1990) The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels. J. Pharmac. exp. Ther. 254, 71-82.
41. 3H]MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines. J. Neurochem. 51, 830.
42. Rowland N. E., Li B.-H., Rozelle A. K., Fregley M. J., Garcia M. and Smith G. C. (1994) Localisation of changes in immediate early genes in brain in relation to hydromineral balance: intravenous angiotensin II. Brain Res. Bull. 33, 427-436.
43. Schurr A., Payne R. S. and Rigor B. M. (1995) Synergism between diltiazem and MK-801 but not AP-V in protecting hippocampal slices against hypoxic damage. Brain Res. 684, 233-236.
44. Shoaib M. and Stolerman I. P. (1992) MK-801 attenuates behavioural adaptation to chronic nicotine administration in rats. Br. J. Pharmac. 105, 514-515.
45. Simpson J. B. (1981) The circumventricular organs and the central actions of angiotensin. Neuroendocrinology 32, 248-256.
46. Simpson J. B. and Routtenberg A. (1973) Subfornical organ: site of drinking elicited by angiotensin II. Science, NY 181, 1172-1174.
47. Sladek C. D. and Joynt R. J. (1979) Cholinergeic involvement in osmotic control of vasopressin release by the organ-cultured rat hypothalamo-neurohypophyseal system. Endocrinology 105, 367-371.
48. Suh H. W., Song D. K., Coi Y. S. and Kim Y. H. (1995) Muitiplicative interaction between intrathecally and intracerebroventricularly administered morphine for antinociception in the mouse: involvement of suprasinal NMDA but not non-NMDA receptors. Life Sci. 56, PL181-PL185.
49. Sun X. and Larson A. A. (1993) MK-801 and phencyclidine act at phencyclidine receptor sites that are not linked to N-methyl-D-aspartate activity to inhibit behavioural sensitization to kainate. Neuroscience 54, 773-779.
50. Tanaka J. and Nomura M. (1993) Involvement of neurons sensitive to angiotensin II in the median preoptic nucleus in the drinking response induced by angiotensin II activation of the subfornical organ in rats. Expl Neurol. 199, 235-239.
51. Van den Pol A. N. (1991) Glutamate and asparate immunoreactivity in hypothalamic presynaptic axons. J. Neurosci. 11, 2087-2101.
52. Van Den Pol A. N., Wuarin J.-P. and Morris M. (1992) Glutamate, the dominant excitatory transmitter in neuroendocrine regulation. Science, NY 250, 1276-1278.
53. Wang E. H. F., Kemp J. A., Priestley T., Knight A. R., Woodruff G. N. and Iversen L. L. (1986) The anticonvulsant MK-801 is a potent N-methyl-D-asparate antagonist. Proc. natn. Acad. Sci. U.S.A. 83, 7104-7108.
54. Wheal H. V. and Thomson A. M. (1991) EAA receptor types. In Excitatory Amino Acid and Synaptic Transmission (eds Wheal H. V. and Thomson A. M.), pp. 1-17. Academic, New York.
55. Woodward D. J., Moises H. C., Waterhouse B. D. and Freedman R. (1979) Modulation actions of norepinephrine in the central nervous system. Fedn Proc. 38, 2109-2116.
56. Xu Z. and Herbert J. (1994) Regional suppression by water intake of c-fos expression induced by intraventricular infusions of angiotensin II. Brain Res. 659, 157-168.
57. Xu Z. and Herbert J. (1995) Regional suppression by the lesions in the anterior third ventricle of c-fos expression induced by either angiotensin II or hypertonic saline. Neuroscience 67, 135-147.
58. Yang X., Buccafusco J. J. and Pauly J. R. (1994) Pharmacological evaluation of methylcarbamylcholine-induced drinking behaviour in rats. Pharmac. Biochem. Behav. 49, 1-6.
59. Ylinen A., Pitkanen M., Sirvio J., Hartikainen T., Sivenius J., Koivisto E. and Riekkinen Sr P. J. (1995) The effects of NMDA receptor antagonists at anticonvulsive doses on the performance of rats in the water maze task. Eur. J. Phamac. 274, 159-165.
60. Zabik J. E., Sprague J. E. and Odio M. (1993) Interactive dopaminergic and noradrenergic systems in the regulation of thirst in the rat. Physiol. Behav. 54, 29-33.